AC Immune S.A. (ACIU)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -57,836 | -60,410 | -74,142 | -79,865 | -66,045 |
| Depreciation Amortization | 2,456 | 2,467 | 2,472 | 2,632 | 2,098 |
| Accounts receivable | 16,811 | -16,486 | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 1,110 | 858 | -1,124 | -92 | 2,322 |
| Other Working Capital | 122,125 | -16,887 | -8,836 | 7,485 | -4,878 |
| Other Operating Activity | -9,877 | 23,169 | 4,539 | -2,031 | 3,022 |
| Operating Cash Flow | $74,790 | $-67,289 | $-77,092 | $-71,870 | $-63,481 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -118,883 | 74,014 | 26,198 | -55,799 | 31,998 |
| PPE Investments | -654 | -892 | -1,298 | -2,883 | -1,751 |
| Other Investing Activity | -61 | 0 | 2 | -32 | -31 |
| Investing Cash Flow | $-119,599 | $73,122 | $24,901 | $-58,714 | $30,216 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | 25,671 | N/A |
| Common Stock Issued | 126 | 48,787 | -1 | 19,477 | 259 |
| Common Stock Repurchased | N/A | N/A | N/A | N/A | -107 |
| Other Financing Activity | -1,398 | -610 | -1,410 | -568 | -1,009 |
| Financing Cash Flow | $-1,272 | $48,176 | $-1,411 | $44,580 | $-857 |
| Exchange Rate Effect | -1,875 | -1,759 | 546 | -77 | -750 |
| Beginning Cash Position | 89,161 | 35,184 | 86,154 | 176,033 | 206,480 |
| End Cash Position | 41,205 | 87,435 | 33,099 | 89,953 | 171,609 |
| Net Cash Flow | $-47,957 | $52,251 | $-53,055 | $-86,081 | $-34,871 |
| Free Cash Flow | |||||
| Operating Cash Flow | 74,790 | -67,289 | -77,092 | -71,870 | -63,481 |
| Capital Expenditure | -654 | -892 | -1,298 | -2,883 | -1,820 |
| Free Cash Flow | 74,136 | -68,181 | -78,390 | -74,753 | -65,300 |